1. Home
  2. MAZE vs CRMT Comparison

MAZE vs CRMT Comparison

Compare MAZE & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAZE
  • CRMT
  • Stock Information
  • Founded
  • MAZE 2018
  • CRMT 1981
  • Country
  • MAZE United States
  • CRMT United States
  • Employees
  • MAZE N/A
  • CRMT N/A
  • Industry
  • MAZE
  • CRMT Other Specialty Stores
  • Sector
  • MAZE
  • CRMT Consumer Discretionary
  • Exchange
  • MAZE NYSE
  • CRMT Nasdaq
  • Market Cap
  • MAZE 367.0M
  • CRMT 389.6M
  • IPO Year
  • MAZE 2025
  • CRMT N/A
  • Fundamental
  • Price
  • MAZE $13.07
  • CRMT $53.28
  • Analyst Decision
  • MAZE Strong Buy
  • CRMT Hold
  • Analyst Count
  • MAZE 3
  • CRMT 2
  • Target Price
  • MAZE $25.67
  • CRMT $50.00
  • AVG Volume (30 Days)
  • MAZE 95.0K
  • CRMT 56.2K
  • Earning Date
  • MAZE 05-14-2025
  • CRMT 06-12-2025
  • Dividend Yield
  • MAZE N/A
  • CRMT N/A
  • EPS Growth
  • MAZE N/A
  • CRMT N/A
  • EPS
  • MAZE 0.34
  • CRMT 1.04
  • Revenue
  • MAZE $167,500,000.00
  • CRMT $1,380,231,000.00
  • Revenue This Year
  • MAZE N/A
  • CRMT N/A
  • Revenue Next Year
  • MAZE N/A
  • CRMT $4.22
  • P/E Ratio
  • MAZE $39.80
  • CRMT $49.97
  • Revenue Growth
  • MAZE N/A
  • CRMT N/A
  • 52 Week Low
  • MAZE $6.71
  • CRMT $36.40
  • 52 Week High
  • MAZE $17.00
  • CRMT $72.26
  • Technical
  • Relative Strength Index (RSI)
  • MAZE N/A
  • CRMT 57.94
  • Support Level
  • MAZE N/A
  • CRMT $51.12
  • Resistance Level
  • MAZE N/A
  • CRMT $53.03
  • Average True Range (ATR)
  • MAZE 0.00
  • CRMT 1.96
  • MACD
  • MAZE 0.00
  • CRMT 0.25
  • Stochastic Oscillator
  • MAZE 0.00
  • CRMT 78.24

About MAZE MAZE THERAPEUTICS INC

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Share on Social Networks: